Recent Advances in Nanotechnology for the Treatment of Dry Eye Disease

Giulia Coco,Giacinta Buffon,Andrea Taloni,Giuseppe Giannaccare

DOI: https://doi.org/10.3390/nano14080669

IF: 5.3

2024-04-12

Nanomaterials

Abstract:Dry eye disease (DED) incidence is continuously growing, positioning it to become an emergent health issue over the next few years. Several topical treatments are commonly used to treat DED; however, reports indicate that only a minor proportion of drug bioavailability is achieved by the majority of eye drops available on the market. In this context, enhancing drug ability to overcome ocular barriers and prolonging its residence time on the ocular surface represent a new challenge in the field of ocular carrier systems. Therefore, research has focused on the development of multi-functional nanosystems, such as nanoemulsions, liposomes, dendrimers, hydrogels, and other nanosized carriers. These systems are designed to improve topical drug bioavailability and efficacy and, at the same time, require fewer daily administrations, with potentially reduced side effects. This review summarizes the different nanotechnologies developed, their role in DED, and the nanotechnology-based eyedrops currently approved for DED treatment.

materials science, multidisciplinary,nanoscience & nanotechnology,physics, applied,chemistry

What problem does this paper attempt to address?

### Problems Addressed by the Paper

This paper aims to address the issue of drug delivery in the treatment of Dry Eye Disease (DED). Specifically:

1. **Current Status of Dry Eye Disease**:
- The incidence of dry eye disease is continuously rising, becoming a significant health issue in the coming years.
- Common eye drops on the market have low bioavailability, with only a small amount of the drug reaching the eye in most cases.

2. **Limitations of Existing Treatments**:
- Current treatment methods include artificial tears, topical corticosteroids, cyclosporine, etc., but these methods have issues such as low bioavailability, the need for frequent administration, and potential side effects.

3. **Advantages of Nanotechnology**:
- Researchers have developed various multifunctional nanosystems (such as nanoemulsions, liposomes, dendrimers, hydrogels, etc.) to improve drug bioavailability and efficacy, reduce the frequency of daily administration, and potentially lower side effects.

In summary, the focus of this paper is to improve ocular drug delivery systems through nanotechnology to overcome physiological barriers, extend the residence time of drugs on the ocular surface, and enhance drug bioavailability, thereby more effectively treating dry eye disease.